Two Sigma Investments, LP Protara Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 19,748 shares of TARA stock, worth $41,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,748

Previous 25,145 21.46%

Holding current value

$41,470

Previous $47,000 68.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.86 - $4.83 $10,038 - $26,067	-5,397 Reduced 21.46%	19,748 $79,000
Q4 2023 Feb 14, 2024	SELL	$1.12 - $1.93 $2,464 - $4,246	-2,200 Reduced 8.05%	25,145 $47,000
Q3 2023 Nov 14, 2023	SELL	$1.64 - $2.93 $12,136 - $21,682	-7,400 Reduced 21.3%	27,345 $45,000
Q2 2023 Aug 14, 2023	SELL	$2.27 - $3.59 $2,270 - $3,590	-1,000 Reduced 2.8%	34,745 $83,000
Q1 2023 May 15, 2023	SELL	$2.76 - $3.91 $28,709 - $40,671	-10,402 Reduced 22.54%	35,745 $111,000

Q4 2022 Feb 14, 2023	SELL	$2.43 - $3.7 $11,909 - $18,133	-4,901 Reduced 9.6%	46,147 $123,000
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.27 $7,475 - $10,674	-2,500 Reduced 4.67%	51,048 $151,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $5.33 $98,646 - $187,781	-35,231 Reduced 39.68%	53,548 $157,000
Q1 2022 May 16, 2022	SELL	$4.19 - $6.9 $425,280 - $700,343	-101,499 Reduced 53.34%	88,779 $454,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $364,959 - $460,501	59,343 Added 45.32%	190,278 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$6.38 - $9.3 $481,881 - $702,429	75,530 Added 136.32%	130,935 $906,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $16.99 $480,915 - $941,330	55,405 New	55,405 $540,000
Q1 2021 May 17, 2021	SELL	$13.75 - $23.86 $393,236 - $682,372	-28,599 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.97 - $25.34 $313,605 - $468,283	18,480 Added 182.63%	28,599 $692,000
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $169,594 - $322,694	10,119 New	10,119 $170,000

Others Institutions Holding TARA

# of Institutions

Shares Held

4.55M

Call Options Held

102K

Put Options Held

18.2K

View Full List

About Protara Therapeutics, Inc.

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $23.7M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

More about TARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Protara Therapeutics, Inc. Transaction History